<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03255148</url>
  </required_header>
  <id_info>
    <org_study_id>SingleOT_REST_S56327</org_study_id>
    <nct_id>NCT03255148</nct_id>
  </id_info>
  <brief_title>Influence of Oxytocin on Resting State Neurophysiological Measures</brief_title>
  <official_title>Influence of Oxytocin on Resting State Neurophysiological Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Foundation Flanders</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators will explore the influence of oxytocin administration on
      several neurophysiological responses (EEG, skin conductance and heart rate) during rest.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oxytocin is known to influence several neurophysiological measures, such as heart rate, EEG
      and skin conductance during specific tasks (e.g., emotion recognition, fear learning and
      extinction). However, not much is known about the influence of oxytocin on those measures
      during rest. Therefore, in this randomized, placebo controlled, double blinded study, the
      investigators will investigate the influence of oxytocin during a resting period of 5
      minutes. Heart rate, skin conductance, respiration and EEG will be measured before and after
      oxytocin or placebo administration. The investigators expect that oxytocin will increase the
      heart rate variability and decrease the skin conductance levels. Exploratory, the
      investigators will conduct a cross-frequency analysis of band power and asses the
      relationship between distinct indexes of sympathetic / parasympathetic balance.

      Please note that this study is part of a larger study in which the investigators also asses
      the influence of oxytocin on neurophysiological responses elicited by direct gaze
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 24, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in heart rate variability after oxytocin administration</measure>
    <time_frame>Assessment over 5 minutes, before and after oxytocin or placebo administration</time_frame>
    <description>The influence of oxytocin administration on heart rate variability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in skin conductance level after oxytocin administration</measure>
    <time_frame>Assessment over 5 minutes, before and after oxytocin or placebo administration</time_frame>
    <description>The influence of oxytocin administration on skin conductance level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Oxytocin</condition>
  <arm_group>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Syntocinon nasal spray (40 IU/ml; oxytocin, product code RVG 03716); single intranasal dose of 24 international units (IU; 3 puffs of 4 IU per nostril)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline natriumchloride solution nasal spray; single intranasal dose (3 puffs per nostril)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>Syntocinon nasal spray</description>
    <arm_group_label>Oxytocin</arm_group_label>
    <other_name>syntocinon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo nasal spray</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  right-handed

          -  male

          -  age between 18 and 35

          -  Normal or adjusted-to-normal vision (with lenses only)

          -  Dutch as mother tongue

        Exclusion Criteria:

          -  not right-handed

          -  female

          -  age below 18 or above 35

          -  Need to wear glasses

          -  Dutch not as mother tongue
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaat Alaerts, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaat Alaerts, PhD</last_name>
    <phone>+32 16 37 64 46</phone>
    <email>kaat.alaerts@kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisa Maes, PhD</last_name>
    <phone>+32 16 37 31 31</phone>
    <email>elisa.maes@kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KU Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaat Alaerts, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2017</study_first_submitted>
  <study_first_submitted_qc>August 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Kaat Alaerts</investigator_full_name>
    <investigator_title>Prof. Dr. Kaat Alaerts</investigator_title>
  </responsible_party>
  <keyword>resting state</keyword>
  <keyword>EEG</keyword>
  <keyword>skin conductance</keyword>
  <keyword>heart rate</keyword>
  <keyword>oxytocin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

